Skip to main content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
J Urban Health. 2003 Jun; 80(2): 291–301.
PMCID: PMC3456285
PMID: 12791805

Attitudes about prescribing take-home naloxone to injection drug users for the management of heroin overdose: a survey of street-recruited injectors in the San Francisco Bay Area

Abstract

Naloxone, an injectable opiate antagonist, can immediately reverse an opiate overdose and prevent overdose death. We sought to determine injection drug users’ (IDUs) attitudes about being prescribed take-home naloxone. During November 1999 to February 2000, we surveyed 82 street-recruited IDUs from the San Francisco Bay Area of California who had experienced one or more heroin overdose events. We used a questiomaire that included structured and open-ended questions. Most respondents (89%) had witnessed an overdose, and 90% reported initially attempting lay remedies in an effort to help companions survive. Only 51% reported soliciting emergency assistance (calling 911) for the last witnessed overdose, with most hesitating due to fear of police involvement. Of IDUs surveyed, 87% were strongly in favor of participating in an overdose management training program to receive take-home naloxone and training in resuscitation techniques. Nevertheless, respontdents expressed a variety of concerning attitudes. If provided naloxone, 35% predicted that they might feel comfortable using greater amounts of heroin, 62% might be less inclined to call 911 for an overdose, 30% might leave an overdose victim after naloxone resuscitation, and 46% might not be able to dissuade the victim from using heroin again to alleviate with drawal symptoms induced by naloxone. Prescribing take-home naloxone to IDUs with training in its use and in resuscitation techniques may represent a life-saving, peer-based adjunct to accessing emergency services. Nevertheless, strategies for overcoming potential risks associated with the use of take-home naloxone would need to be emphasized in an overdose management training program.

Full Text

The Full Text of this article is available as a PDF (77K).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

1. What America’s Users Spend on Illegal Drugs. Washington, DC: Executive Office of the President.; 1997. [Google Scholar]
2. Drucker E, Garfield J. Overdose trends in five US citres: 1988–1997. Paper presented at: Preventing Heroin Overdose: Pragmatic Approaches; January 13–14, 2000; Seattle, WA.
3. Year-end Emergency Department Data From the Drug Abuse Warning Network (DAWN) Rockville, MD: Dept of Health and Human Services, Substance Abuse and Mental Health Services Administration; 1999. [Google Scholar]
4. Annual Report. San Francisco, CA: San Francisco Department of Public Health; 1998–1999. [Google Scholar]
5. Seal KH, Kral AH, Gee L, et al. Predictors and prevention of nonfatal overdose among street-recruited injection heroin users in the San Francisco Bay Area, 1998–1999. Ann J Public Health. 2001;91:1842–1846. doi: 10.2105/AJPH.91.11.1842. [PMC free article] [PubMed] [CrossRef] [Google Scholar]
6. Darke S, Ross J, Hall W. Overdose among heroin users in Sydney, Australia: I. Pprevalence and correlates of non-fatal overdose. Addiction. 1996;91:405–411. doi: 10.1111/j.1360-0443.1996.tb02289.x. [PubMed] [CrossRef] [Google Scholar]
7. Darke S, Zador D. Fatal heroin “overdose”: a review. Addiction. 1996;91:1765–1772. doi: 10.1111/j.1360-0443.1996.tb03800.x. [PubMed] [CrossRef] [Google Scholar]
8. Zador D, Sunjic S, Darke S. Herbin-related deaths in New South Wales, 1992: toxicological findings and circumstances. Med J Aust. 1996;164:204–207. [PubMed] [Google Scholar]
9. Levine B, Green D, Smialek JE. The role of ethanol in heroin deaths. J Forensic Sci. 1995;40:808–810. [PubMed] [Google Scholar]
10. Powis B, Strang J, Griffiths P, et al. Self-reported overdose among injecting drug users in London: extent and nature of the problem. Addiction. 1999;94:471–478. doi: 10.1046/j.1360-0443.1999.9444712.x. [PubMed] [CrossRef] [Google Scholar]
11. Taylor A, Frischer M, Goldberg D. Non-tatal overdosing is related to polydrug use in Glasgow [letter; comment] BMJ. 1996;313:1400–1401. [PMC free article] [PubMed] [Google Scholar]
12. Darke S, Hall W. The distribution of naloxone to heroin users. Addiction. 1997;92:1195–1199. doi: 10.1111/j.1360-0443.1997.tb03681.x. [PubMed] [CrossRef] [Google Scholar]
13. Sporer KA. Acute heroin overdose. Ann Intern Med. 1999;130:584–590. [PubMed] [Google Scholar]
14. Darke S, Ross J, Hall W. Overdose among heroin users in Sydney, Australia: II. responses to overdose. Addiction. 1996;91:413–417. doi: 10.1111/j.1360-0443.1996.tb02290.x. [PubMed] [CrossRef] [Google Scholar]
15. Strang J, Best D, Man L, Noble A, Gossop M. Peer-mitiated overdose resuscitation: fellow drug users could be mobilized to implement resuscitation. Int J Drug Policy. 2000;11:437–445. doi: 10.1016/S0955-3959(00)00070-0. [PubMed] [CrossRef] [Google Scholar]
16. Giuliano R. Drug users’ tools of the trade: naloxone and Narcan. Harm Reduction Commun. 1999;9:18–19. [Google Scholar]
17. Physician’s Desk Reference. Montevale, NJ: Medical Economics; 2000.
18. Shulgin A. Controlled Substances: Chemical and Legal Guide to Federal drug Laws. Berkeley, CA: Ronin Publishing, Inc.; 1992. [Google Scholar]
19. Goldfrank LR, Hoffman RS. The poisoned patient with altered consciousness. Controversies in the use of a “coma cocktail” JAMA. 1995;274:562–569. doi: 10.1001/jama.274.7.562. [PubMed] [CrossRef] [Google Scholar]
20. Dettmer K, Naloxone distribution to drug addicts as a contribution to the prevention of opiate overdose fatalities. Paper presented at: Preventing Heroin overdose: Pragmatic Approaches; January 13–14, 2000; Seattle, WA.
21. Ronconi S. Prevention of overdoses among current heroin users in Torino, Italy, for the period 1995–1998. Paper presented at: Preventing Heroin Overdose: Pragmatic Approaches; January 13–14, 2000; Seattle, WA.
22. Bigg D. Dats on take home naloxone are unclear but not condemnatory [letter] BMJ. 2002;324:678–678. doi: 10.1136/bmj.324.7338.678. [PMC free article] [PubMed] [CrossRef] [Google Scholar]
23. Strang J, Powis B, Best D, et al. Preventing opiate overdose fatalities with take-home naloxone: pre-launch study of possible impact and acceptability. Addiction. 1999;94:199–204. doi: 10.1046/j.1360-0443.1999.9421993.x. [PubMed] [CrossRef] [Google Scholar]
24. Lenton SR, Hargreaves KM. Should we conduct a trial of distributing naloxone to heroin users for peer administration to prevent fatal overdose? Med J Aust. 2000;173:260–263. [PubMed] [Google Scholar]
25. Watters JK. Trends in risk behavior and HIV seroprevalence in heterosexual injection drug users in San Francisco, 1986–1992. J Acquir Immune Defic Syndr. 1994;7:1276–1281. [PubMed] [Google Scholar]
26. Kral AH, Bluthenthal RN, Lorvick J, Gee L, Bacchetti P, Edlin BR. Sexual transmission of HIV-1 among injection drug users in San Francisco, USA: risk-factor analysis. Lancet. 2001;357:1397–1401. doi: 10.1016/S0140-6736(00)04562-1. [PubMed] [CrossRef] [Google Scholar]
27. Watters JK, Biernacki P. Targeted sampling: options for the study of hidden populations. Soc Problems. 1989;36:416–430. [Google Scholar]
28. Bluthenthal RN, Watters JK. Multimethod research: from targeted sampling to HIV risk behaviors. In: Lambert EY, Ashery RS, Needle RH, editors. Qualitative Methods in the Prevention of Drug Abuse and HIV Research. Rockville, MD: National Institute on Drug Abuse; 1995. pp. 212–230. [PubMed] [Google Scholar]
29. Darke S, Hall W, Weatherburn D, Lind B. Fluctuations in heroin purity and the incidence of fatal heroin overdose. Drug Alcohol Depend. 1999;54:155–161. doi: 10.1016/S0376-8716(98)00159-8. [PubMed] [CrossRef] [Google Scholar]
30. Bammer G, Sengoz A. Non-fatal heroin overdoses [letter] Med J Aust. 1994;161:572–573. [PubMed] [Google Scholar]
31. Gossop M, Griffiths P, Powis B, Williamson S, Strang J. Frequency of non-fatal heroin overdose: survey of heroin users recruited in non-clinical settings. BMJ. 1996;313:402–402. [PMC free article] [PubMed] [Google Scholar]
32. Levy JA, Gallmeier CP, Weibel WW. The outreach assisted peer-support model for controlling drug dependency. J Drug Issues. 1995;25:507–529. [Google Scholar]
33. Hawkins WE, Latkin C, Mandel W, Oziemkowska M. Do actions speak louder than words? Perceived peer influences on needle sharing and cleaning in a sample of injection drug users. AIDS Educ Prev. 1999;11:122–131. [PubMed] [Google Scholar]
34. Broadhead RS, Heckathorn DD, Weakliem DL, et al. Hernessing peer networks as an instrument for AIDS prevention: results from a peer-driven intervention. Public Health Rep. 1998;113(Suppl 1):42–57. [PMC free article] [PubMed] [Google Scholar]
35. Burris S, Noreland J, Edlin B. Legal aspects of providing naloxone to heroin users in the United States. Int J Drug Policy. 2001;12:237–248. doi: 10.1016/S0955-3959(01)00080-9. [CrossRef] [Google Scholar]
36. Sporer KA, Firestone J, Isaacs SM. Out of-hospital treatment of opioid overdoses in an urban setting. Acad Emerg Med. 1996;3:660–667. doi: 10.1111/j.1553-2712.1996.tb03487.x. [PubMed] [CrossRef] [Google Scholar]
37. Smith DA, Leake L, Loflin JR, Yealy DM. Is admission after intravenous heroin overdose necessary? Ann Emerg Med. 1992;21:1326–1330. doi: 10.1016/S0196-0644(05)81896-7. [PubMed] [CrossRef] [Google Scholar]
38. Vilke GM, Buchanan J, Dunford JV, Chan TC. Are heroin overdose deaths related to patient release after prehospital treatment with naloxone? Prehosp Emerg Care. 1999;3:183–186. [PubMed] [Google Scholar]
39. Centers for Disease Control and Prevention Unintentional overdose in King County, Washington, 1990–1999. MMWR Morb Mortal Wkly Rep. 2000;49:633–636. [PubMed] [Google Scholar]
40. Centers for Disease Control and Prevention Herbin overdose deaths—Multnomah County, Oregon, 1993–1999. MMWR Morb Mortal Wkly Rep. 2000;49:633–636. [PubMed] [Google Scholar]
41. Watters JK, Needle R, Brown BS, Weatherby N, Booth R, Williams M. The self-reporting of cocaine use. JAMA. 1992;268:2374–2375. doi: 10.1001/jama.268.17.2374. [PubMed] [CrossRef] [Google Scholar]
42. Dowling-Guyer S, Johnson ME, Fisher DG, et al. Relability of drug user’s self-reported HIV risk behaviors and validity of self-reported recent drug use. Assessment. 1994;1:383–392. [Google Scholar]

Articles from Journal of Urban Health : Bulletin of the New York Academy of Medicine are provided here courtesy of New York Academy of Medicine